EXPLORE THE UNIVERSITY OF OXFORD'S WORLD-CLASS RESEARCH

1 entry found
1
Journal article icon
Journal article

Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study

  • Coates, L, Gladman, D, Nash, P, et al.
  • 2018-12-07
File available icon
Peer reviewed icon
Link to publisher copy available icon
FILTER RESULTS

TO TOP